erythropoietin

英[ɪrɪθrə'pɔɪətɪn] 美[ɪˌrɪθroʊpɔɪ'iːtɪn]
  • n. [生化](促)红细胞生成素
Noun:
  1. a glycoprotein secreted by the kidneys that stimulates the production of red blood cells

1. Objective To find the detecting method of erythropoietin (EPO).
目的探索兴奋剂促红细胞生成素(EPO)的检测方法。

youdao

2. Erythropoietin (EPO) is widely used in clinical and basic studies.
红细胞生成素(EPO)在临床和基础研究中应用广泛。

youdao

3. Hepatology Digest: What about in China and the use of erythropoietin?
国际肝病:在中国促红细胞生成素的应用如何?

youdao

4. BACKGROUND: Recombinant human erythropoietin is commonly used for treatment of anaemia.
背景:重组体人红细胞生成素通常用于治疗贫血。

youdao

5. Objective: Introduce the application of erythropoietin to premature infants with anemia.
目的介绍红细胞生成素在早产儿的应用。

youdao

6. Objective: to study the use of erythropoietin receptor in anemia of chronic renal failure.
目的:探讨促红细胞生成素受体在慢性肾功能衰竭肾性贫血中的表达及意义。

youdao

7. Erythropoietin (EPO) is a kind of endogenesis cell factor which was excreted by the kidney.
促红细胞生成素(EPO)是由肾脏分泌的内源性细胞因子。

youdao

8. The medium formulation have been studied to culture CHO cells producing erythropoietin(EPO).
研究了用中国仓鼠卵巢细胞(CHO)生产促红细胞生成素(EPO)的配方。

youdao

9. Objective To investigate the prevention effect of erythropoietin on chemotherapy-induced anemia.
目的探讨红细胞生成素对小鼠化疗所致贫血的预防作用。

youdao

10. Objective: To study the use of erythropoietin receptor (EPOR) in anemia of chronic renal failure.
目的:探讨促红细胞生成素受体(EPOR)在慢性肾功能衰竭肾性贫血中的表达及意义。

youdao

11. Moreover, erythroid colonies could be grown from blood samples without the need for exogenous erythropoietin.
此外,在没有促红细胞生成素的血样中红细胞可以繁殖。

youdao

12. Aim To study the effect of high C-reactive protein (CRP) on dose of erythropoietin (EPO) in hemodialysis patients.
目的研究高血清c反应蛋白(CRP)对血液透析患者促红细胞生成素(EPO)治疗效果的影响。

youdao

13. Effects of erythropoietin or nitric oxide synthesis inhibitor on hyperdynamic circulatory state in cirrhotic rats.
促红细胞生成素与一氧化氮合酶抑制剂对肝硬化大鼠高动力循环状态的影响。

youdao

14. The intake of protein and calorie, metabolic acidosis and erythropoietin affect the nutritional status of patients.
蛋白质和能量摄入、酸中毒及红细胞生成素对营养指标有影响。

youdao

15. Results: Show the dose, methods and side effects of recombinant human erythropoietin to premature infants with anemia.
结果展示人类重组红细胞生成素在早产儿贫血中应用的剂量、方法、副作用。

youdao

16. Objective: To investigate in vitro release characteristics of collagen double layer minipellet of erythropoietin(EPO).
前言: 目的:对红细胞生成素胶原蛋白双层微条的体外释放特性进行研究。

youdao

17. Background: Erythropoietin is a naturally occurring hormone with multiple effects on a number of different cell types.
背景资料:促红细胞生成素是一种天然存在的激素,对能对各种不同的细胞发挥多种作用。

youdao

18. The IOC Medical Commission has approved a test to detect the use of the banned synthetic hormone erythropoietin, or EPO.
国际奥委会药物委员会已经通过了一项测试来检测违禁使用合成激素红细胞生成素(简称EPO)的情况。

youdao

19. Objective: To explore the relationship between erythropoietin level and hemoglobin concentration in patients with anemia.
目的:探讨贫血患者红细胞生成素水平与血红蛋白浓度的关系。

youdao

20. Objective To study the relationship between levels of serum erythropoietin and haemoglobin in patients with anemia of cancer.
目的研究癌性贫血患者血清促红细胞生成素水平及其与血红蛋白含量之间的关系。

youdao

21. Erythropoietin, the principal regulator of erythroids progenitor cells, is widely used to treat anemia caused by many diseases.
促红细胞生成素是一种造血因子,临床中广泛应用于治疗各种原因造成的贫血。

youdao

22. Objective To explore erythropoietin(EPO) and ferrous sulfate therapy used to autohemotherapy(AHT) in the child cardiac operation.
目的探讨促红细胞生成素和硫酸亚铁治疗用于小儿心脏手术的术前自体献血(AHT)。

youdao

23. Objective: To evaluate the impact of erythropoietin on clinical parameters of patients with acute renal failure and the prognosis.
目的:了解促红细胞生成素治疗对于急性肾功能衰竭患者肾衰竭临床指标及预后的影响。

youdao

24. It has been proved that erythropoietin has neuroprotective effect and therapeutic action on cerebral ischemia in vivo and in vitro.
体外细胞培养及动物实验证明,促红细胞生成素对脑缺血损伤具有神经保护和治疗作用。

youdao

25. Recombinant human erythropoietin abuse should not be judged by any upper limit but judged by the unusual changes of blood parameters.
血检不应设置限制数值,而应以运动血液参数的异常变化作为依据。

youdao

26. When anemia in these patients is treated with erythropoietin, a significant improvement in cardiac function and symptoms was observed.
用促红细胞生成素治疗心力衰竭中的贫血,能够使心力衰竭患者的心功能和临床症状明显改善。

youdao

27. I think while there has been some discussion at this conference about the use of erythropoietin, and it is generally used more in the U.
这次会议已经有一些关于促红细胞素应用的讨论,它在美国的应用要多于欧洲,而它在西方国家的应用要比世界上其他地方更广泛。

youdao

28. Hemoglobin concentration and the number of reticulocyte decreased greatly, while serum erythropoietin (EPO) level increased significantly.
结果血红蛋白浓度和网织红细胞数目明显减少,血清红细胞生成素水平明显增加。

youdao

29. Hemoglobin concentration and the number of reticulocyte decreased greatly, while serum erythropoietin (EPO) level increased significantly.
结果血红蛋白浓度和网织红细胞数目明显减少,血清红细胞生成素水平明显增加。

youdao

    用作名词 (n.)
    1. Released kidney lysosomal enzymes may be concerned in the generation of erythropoietin.
      释放的肾脏溶酶体的酶可能与产生促红细胞生成素有关。
    2. Erythropoietin, as well as its receptor, is present in the central and peripheral nervous system.
      促红细胞生成素及其受体在中枢神经和周围神经均有存在。

erythropoietin的相关资料: